Following the idea of incorporating drugs onto the stent surface, several substances have already been used in DESs.

Milestones.

  1. Database of drugs used in urinary stents (M30).
  2. Creation of Report to agree the specifications drugs must accomplish to be released by urinary stents (M44).

D5. Report on Drugs assessed for DESs to reduce the urinary stents's morbidity, including scientific papers and TS, meetings, WkS and STSM related to the WG5 of the Action (M44).

Leader: Gianluca Ciardelli
Vice-Leader: Martin Järvekülg


We are processing your form, please wait.

Update in urinary stents. Indications-Complications-Technology. Theory & Practice

26-27 November, Cáceres, Spain


Training school admission is free of charge and we very much hope that you are interested to participate. For registration to the training school, please fill in and submit the online form until 5th November 2018.

Participate! Learn More